In an orthotopic mouse model using U87MG glioma cells, TIGAR knockdown prolonged the survival of tumor-bearing mice and enhanced the radiosensitivity of xenografts overexpressing thioredoxin reductase-1 (TRXR1) [14]. Here, TIGAR is linked to glioma.